Breaking

Poland calls on US to place nukes within its borders amid Russia threat
Russian border states eye exit of landmine treaty to fortify defenses and deter Putin
‘This is no drill’: China’s dominance over US shipbuilding sparks bipartisan effort
Trump’s pick for NIH director clears committee, heads to full Senate vote
Dr. Marty Makary advances out of key committee in bid for FDA confirmation
White House pulls nomination of David Weldon as CDC director
FDA chief counsel who defended abortion pill access under Biden resigns two days into job
Opawica Explorations’ Bazooka Project: A Key Potential Asset in Abitibi Gold Rush

Politics
Business
World
Investing
Search for:

Investing

Clinical trial data shows RAD 101 detects Brain Metastases

February 10, 2025

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced Clinical trial data shows RAD 101 detects Brain Metastases

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Cizzle Brands Corporation Schedules Second Fiscal Quarter 2025 Financial Results Webcast for Thursday, March 27, 2025 at 4:30 PM ET

Opawica Explorations’ Bazooka Project: A Key Potential Asset in Abitibi Gold Rush

CHARBONE Hydrogene et ABB signent une entente pour accelerer les usines de production d’hydrogene vert en Amerique du Nord

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (1,542)
- Investing (4,246)
- Politics (6,630)
- Uncategorized (3)
- World (5,502)

Disclaimer: usaandshares.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest

Copyright © 2023 usaandshares.com | All Rights Reserved

Top

Politics
Business
World
Investing

Type above and press Enter to search. Press Esc to cancel.